1. Role of Brain-Derived Neurotrophic Factor in the Aetiology of Depression

   • Eero Castrén
   • Tomi Rantamäki

   Leading Article 29 August 2012 Pages: 1 - 7

2. Progress in Defining Optimal Treatment Outcome in Schizophrenia

   • Gary Remington
   • George Foussias
   • Ofer Agid

   Leading Article 29 August 2012 Pages: 9 - 20

   

3. Role of Antiepileptic Drugs as Preventive Agents for Migraine

   • Michail Vikelis
   • Alan M. Rapoport

   Review Article 29 August 2012 Pages: 21 - 33

4. Safety Reporting and Adverse-Event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-Phase Treatment of Adults with Depression

   • Norio Watanabe
   • Ichiro M. Omori
   • Toshi A. Furukawa

   Original Research Article 29 August 2012 Pages: 35 - 53

   

5. Factors Associated with Serious Adverse Reactions to Cholinesterase Inhibitors

   • Antoine Pariente
   • Dina Joseph-Reinette Sanctussy
   • Annie Fourrier-Réglat

   Original Research Article 29 August 2012 Pages: 55 - 63

   

6. Blonanserin

   • Emma D. Deeks
   • Gillian M. Keating

   Adis Drug Evaluation 29 August 2012 Pages: 65 - 84

   

7. Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescentsy

   • Karly P. Garnock-Jones
   • Gillian M. Keating

   Adis Spotlight 29 August 2012 Pages: 85 - 88